CClinicalTrials.gg
CompletedNCT07132853PAL-PACUpdated Sep 15, 2025

Assessment of Physical Activity Levels in Patients With Cardiac Arrhythmias

An observational study in Arrhythmia and Physical Activity, sponsored by University of Sao Paulo. Completed at 1 site in Brazil. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-09-15.

Sponsored by University of Sao Paulo · Observational

Study type
Observational
Model
Case-only
Time perspective
Cross-sectional
Enrollment
100
Ages
18 Years and older
Sex
All
01

Study summary

Physical activity is defined as any bodily movement that results in energy expenditure. Athletes are individuals who engage in planned, structured physical exercise under guidance, with specific goals and competitive objectives. For this population, pre-participation cardiovascular screening is well established, aiming to identify cardiac conditions that may lead to sudden death and/or cardiovascular events. However, athletes represent a minority of patients attending cardiac arrhythmia outpatient clinics. Most patients are either sedentary or engage in-or wish to engage in-some form of physical activity, but are often discouraged for various reasons, leading to increased physical inactivity. This occurs despite the well-documented benefits of physical activity across all age groups and various forms of heart disease, including improved quality of life, reduced depression and anxiety, and enhanced overall well-being. Despite existing recommendations, the prevalence of physically active individuals among patients followed at the Arrhythmia Outpatient Clinic of the Heart Institute (InCor) of the Hospital das Clínicas, University of São Paulo, remains unknown. Understanding these factors through such mapping may contribute to improved clinical management and potentially enhance the quality of life of patients with cardiac arrhythmias.

02

Conditions studied

  • Arrhythmia
  • Physical Activity

Keywords

  • arrythmia
  • physical activity
03

In context

Arrhythmias, Cardiac

885 studies on the registry are indexed under Arrhythmias, Cardiac; 235 are open to participants now.

This study's enrollment of 100 is below the median of 200 across 414 observational studies indexed under Arrhythmias, Cardiac.

Browse Arrhythmias, Cardiac studies →

Lead sponsor

University of Sao Paulo is the lead sponsor of 1,005 studies on the registry; 90 are open to participants now.

Of its 7 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Sampling method
Non-probability sample

Study population

A convenience sample of 100 consecutive patients followed at the arrhythmia outpatient clinic of InCor - HCFMUSP.

Inclusion criteria

  1. Individuals with a documented diagnosis of arrhythmia who are followed at the arrhythmia outpatient clinic of InCor.
  2. Signed informed consent form or assent form.

Exclusion criteria

Exclusion Criteria:

  1. Bedridden patients or those with mobility impairments.
  2. Patients with advanced-stage diseases (estimated life expectancy of less than one year).
  3. Patients participating in other studies.
05

Study design

Observational model
Case-only
Time perspective
Cross-sectional
Enrollment
100 participants (actual)
Patient registry
No

Groups and cohorts

  • Arrhythmia

    Physical activity level description

06

What researchers measure

Primary outcomes

  1. SF-12 Health Survey

    Quality of life was assessed using SF-12's Physical and Mental scores.

    Time frame: Baseline

Secondary outcomes

  1. International Physical Activity Questionnaire (IPAQ)

    Describe the physical activity level by IPAQ

    Time frame: Baseline

07

Study locations

1 site
  • Heart Institute
    São Paulo, São Paulo 05403-900, Brazil
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 15, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07132853
Lead sponsor
University of Sao Paulo
Responsible party
Savia Christina Pereira Bueno (Principal Investigator, University of Sao Paulo) — Principal investigator
First posted
Aug 20, 2025
Start date
Nov 25, 2021
Primary completion
Aug 15, 2023
Completion
Aug 22, 2023
Last update
Sep 15, 2025

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion